IntraBio Inc. Secures Orphan Medicinal Product Designation for CACNA1A Disorders
Positive Opinion Paves Way for Phase III Trial of Acetylleucine in Rare Neurological Conditions Why are rare neurological disorders often overlooked in drug development? IntraBio Inc., an Austin, Texas-based global biopharmaceutical…
Five Discovery Launches to Repair Dysfunctional Brain Circuits in Neurodegenerative Disease
Biotech Firm to Present at Psychedelic Therapeutics Conference in New Orleans Why are current treatments for neurodegenerative diseases often limited to symptom management? Five Discovery, a biotechnology company, is addressing…
MiraDx Launches PROSTOX™ Standard to Personalize Prostate Cancer Radiation Therapy
Expanding Access to Personalized Radiation Therapy for Prostate Cancer Patients Why do more than 20% of prostate cancer patients experience persistent urinary side effects after radiation therapy? MiraDx, a molecular diagnostics…
OmniAb, Inc. to Present at Leerink Global Healthcare Conference in March 2026
Biotech Leader OmniAb, Inc. to Showcase Cutting-Edge Antibody Discovery Technology In the rapidly evolving landscape of biotechnology, where innovation and precision are paramount, OmniAb, Inc. stands out as a leader…
Veracyte Advances Urologic Cancer Care With Robust Data at 2026 ASCO GU Symposium
Veracyte Showcases Over 15 Abstracts Highlighting Decipher and TrueMRD Genomic Tests What if genomic tests could revolutionize the way we treat urologic cancers? Veracyte, Inc. a leading cancer diagnostics company,…
NorthX Biologics and Demeetra Collaborate to Accelerate Biologics Development
Strategic Partnership Combines Best-in-Class Cell Line Development and GMP Manufacturing Why do biotech companies often face long development cycles and costly delays? NorthX Biologics and Demeetra have formed a strategic…
ClearNote Health Launches Enhanced Avantect® Pancreatic Cancer Test
ClearNote Health Enhances Early Detection of Pancreatic Cancer with New Avantect® Test Why is early detection of pancreatic cancer so critical? ClearNote Health, a company dedicated to improving early detection…
Gossamer Bio Announces Topline Results for Phase 3 PROSERA Study of Seralutinib in PAH
Gossamer Bio Reports Mixed Results for Seralutinib in PAH, Demonstrates Strong Efficacy in High-Risk Subgroups Is the current landscape of pulmonary arterial hypertension (PAH) treatments failing to meet the needs…
Synthekine Inc. Appoints John A. Orwin as Board Chair to Lead Clinical Expansion
Biotech Leader Takes Helm as Synthekine Advances Phase 2 Cancer Study In the rapidly evolving landscape of biotechnology, where precision and innovation are paramount, Synthekine Inc. is making a strategic…
Integrated DNA Technologies Unveils Next-Generation Sequencing Innovations for Cancer Research
IDT Launches Advanced NGS Portfolio to Tackle Key Bottlenecks in Cancer Research As cancer research enters a new era defined by ultra-sensitive identification and rapidly expanding biomarker landscapes, Integrated DNA…
Atara Biotherapeutics Extends Milestone Payment Deadline to 2028
Atara Biotherapeutics Secures Flexibility for Tabelecleucel Development Why is the timing of milestone payments crucial for biotech companies? Atara Biotherapeutics, Inc. a leader in T-cell immunotherapy, has secured an extension…
Organon Expands Women’s Health Portfolio With MIUDELLA Copper IUD
Global Healthcare Leader Organon Licenses Sebela Pharmaceuticals’ MIUDELLA for Diverse Reproductive Health Needs Why is the landscape of women’s reproductive health evolving so rapidly? Organon a global healthcare company with…